Header Logo

Jeffrey A. Borgia

TitleAssociate Professor
InstitutionRush University, Rush Medical College
DepartmentAnatomy and Cell Biology
AddressChicago IL 60612
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Director, Rush University Cancer Center Biorepository.
    Director, Rush Biomarker Development Core.

    My Scopus ID is 6602993443.
    My NIH COMMONS name is JBORGIA.

    Research Areas:
    My research is primarily focused on the development of novel diagnostic tests based on ‘Omic’-level profiling of patient specimens and/or mechanistic insights for pathophysiology. As the Director of the Rush Cancer Center Biorepository, I oversee the collection and annotation of patient specimens to support translational research projects and clinical trials that are ongoing in the Rush University Cancer Center. My role as the Director of the Rush Biomarker Development Core permits me to facilitate the administration of ‘state of the art’ services aimed at the discovery and development of novel biomarkers aimed at altering treatment decisions in the clinics, ranging from early cancer detection to personalized treatment selection for patients. Platforms supported include quantitative mass spectrometry and custom Luminex immunoassays that, combined with accompanying laboratory automation and skilled personnel, generate very high-throughput biomarker discovery, assay development (with analytical validation), and routine specimen processing.

    In response to the global Covid-19 pandemic my laboratory has developed a novel multiplex serological test that has been submitted for FDA approval under the Emergency Use Authorization. This assay quantitatively evaluates an immune response to the SARS-CoV-2 virus, including antibodies associated with viral neutralization. Further, my lab has partnered with Dr. Jeffrey Schneider and Dr. João Mamede to provide a functional assessment of SARS-CoV-2 neutralization through an ‘in house’ developed pseudovirus neutralization assay.

    My Faculty Profile at Rush University Medical Center:
    https://www.rushu.rush.edu/faculty/jeffrey-borgia-phd

    My Laboratory:
    https://www.rushu.rush.edu/research/departmental-research/cell-molecular-medicine-research/laboratory-jeffrey-borgia-phd

    My NCBI Bibliography:
    https://www.ncbi.nlm.nih.gov/myncbi/browse/collection/40797756/?sort=date&direction=descending

    My Scopus:
    https://www.scopus.com/authid/detail.uri?authorId=6602993443

    Education:
    PhD, University of Minnesota, Twin Cities
    BS, Eckerd College

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Aboushaala K, Chee AV, Toro SJ, Vucicevic R, Yuh C, Dourdourekas J, Patel IK, Espinoza-Orias A, Oh C, Al-Harthi L, Karppinen J, Goldberg EJ, Phillips FM, Colman M, Williams FMK, Borgia JA, Green S, Forsyth C, An HS, Samartzis D. Discovery of circulating blood biomarkers in patients with and without Modic changes of the lumbar spine: a preliminary analysis. Eur Spine J. 2024 Mar 07. PMID: 38451373.
      Citations:    
    2. Anderson KD, Beckmann C, Heermant S, Ko FC, Dulion B, Tarhoni I, Borgia JA, Virdi AS, Wimmer MA, Sumner DR, Ross RD, Anderson KD, Beckmann C, Heermant S, Ko FC, Dulion B, Tarhoni I, Borgia JA, Virdi AS, Wimmer MA, Sumner DR, Ross RD. Zucker Diabetic-Sprague Dawley Rats Have Impaired Peri-Implant Bone Formation, Matrix Composition, and Implant Fixation Strength. JBMR Plus. 2023 Nov; 7(11):e10819. PMID: 38025036; PMCID: PMC10652173.
      Citations:    
    3. Auger C, Moudgalya H, Neely MR, Stephan JT, Tarhoni I, Gerard D, Basu S, Fhied CL, Abdelkader A, Vargas M, Hu S, Hulett T, Liptay MJ, Shah P, Seder CW, Borgia JA. Development of a Novel Circulating Autoantibody Biomarker Panel for the Identification of Patients with 'Actionable' Pulmonary Nodules. Cancers (Basel). 2023 Apr 12; 15(8). PMID: 37190187.
      Citations:    
    4. Ash MK, Bhimalli PP, Cho BK, Mattamana BB, Gambut S, Tarhoni I, Fhied CL, Reyes AF, Welninski SJ, Arivalagan J, Negr?o F, Goel R, Beck TL, Hope TJ, Sha BE, Goo YA, Al-Harthi L, Mamede JI, Borgia JA, Kelleher NL, Schneider JR. Bulk IgG glycosylation predicts COVID-19 severity and vaccine antibody response. Cell Rep. 2022 12 13; 41(11):111799. PMID: 36493786.
      Citations:    
    5. Wakefield CJ, Lund N, Coughlin J, Karush JM, Geissen N, Alex G, Liptay MJ, Borgia JA, Shah P, Seder CW. The association between thoracic sarcopenia and survival is gender specific in early-stage lung cancer. J Thorac Dis. 2022 Nov; 14(11):4256-4265. PMID: 36524067.
      Citations:    
    6. Jeanblanc N, Jackson L, Gawel S, Brophy S, Vaidya S, Syed S, Davis GJ, Borgia JA. Development of exploratory algorithms to aid in risk of malignancy prediction of indeterminate pulmonary nodules. Clin Chim Acta. 2022 Oct 01; 535:197-202. PMID: 36087784.
      Citations:    
    7. Khaliq AM, Erdogan C, Kurt Z, Turgut SS, Grunvald MW, Rand T, Khare S, Borgia JA, Hayden DM, Pappas SG, Govekar HR, Kam AE, Reiser J, Turaga K, Radovich M, Zang Y, Qiu Y, Liu Y, Fishel ML, Turk A, Gupta V, Al-Sabti R, Subramanian J, Kuzel TM, Sadanandam A, Waldron L, Hussain A, Saleem M, El-Rayes B, Salahudeen AA, Masood A. Refining colorectal cancer classification and clinical stratification through a single-cell atlas. Genome Biol. 2022 05 11; 23(1):113. PMID: 35538548.
      Citations:    
    8. Pohlman AW, Moudgalya H, Jordano L, Lobato GC, Gerard D, Liptay MJ, Seder CW, Borgia JA. The role of IGF-pathway biomarkers in determining risks, screening, and prognosis in lung cancer. Oncotarget. 2022; 13:393-407. PMID: 35198099.
      Citations:    
    9. Fhied CL, Tarhoni I, Gerard D, Lewin GM, Moudgalya H, Schneider JR, Borgia JA. Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19. J Vis Exp. 2022 02 16; (180). PMID: 35253789.
      Citations:    
    10. Duan L, Calhoun S, Perez RE, Macias V, Mir F, Pergande MR, Gattuso P, Borgia JA, Maki CG. Prolyl Carboxypeptidase Maintains Receptor Tyrosine Kinase Signaling and Is a Potential Therapeutic Target in Triple Negative Breast Cancer. Cancers (Basel). 2022 Jan 31; 14(3). PMID: 35159006.
      Citations:    
    11. Skertich NJ, Chu F, Tarhoni IAM, Szajek S, Borgia JA, Madonna MB. Expression of Immunomodulatory Checkpoint Molecules in Drug-Resistant Neuroblastoma: An Exploratory Study. Cancers (Basel). 2022 Jan 31; 14(3). PMID: 35159017.
      Citations:    
    12. Manshad AS, Ballout FA, Borgia JA, Reiser J, Okwuosa TM. Soluble Urokinase Plasminogen Activator Receptor Is Associated With Subclinical Myocardial Impairment by Speckle Tracking Echocardiography in Lung Cancer Patients. Front Cardiovasc Med. 2021; 8:659524. PMID: 35155590.
      Citations:    
    13. Larsen BM, Kannan M, Langer LF, Leibowitz BD, Bentaieb A, Cancino A, Dolgalev I, Drummond BE, Dry JR, Ho CS, Khullar G, Krantz BA, Mapes B, McKinnon KE, Metti J, Perera JF, Rand TA, Sanchez-Freire V, Shaxted JM, Stein MM, Streit MA, Tan YC, Zhang Y, Zhao E, Venkataraman J, Stumpe MC, Borgia JA, Masood A, Catenacci DVT, Mathews JV, Gursel DB, Wei JJ, Welling TH, Simeone DM, White KP, Khan AA, Igartua C, Salahudeen AA. A pan-cancer organoid platform for precision medicine. Cell Rep. 2021 07 27; 36(4):109429. PMID: 34320344.
      Citations:    
    14. Skertich NJ, Chu F, Tarhoni IA, Szajek S, Borgia JA, Madonna MB. Expression of programmed death ligand 1 in drug-resistant osteosarcoma: An exploratory study. Surg Open Sci. 2021 Oct; 6:10-14. PMID: 34386763.
      Citations:    
    15. Yun NK, Rouhani SJ, Bestvina CM, Ritz EM, Gilmore BA, Tarhoni I, Borgia JA, Batus M, Bonomi PD, Fidler MJ. Neutrophil-to-Lymphocyte Ratio Is a Predictive Biomarker in Patients with Epidermal Growth Factor Receptor (EGFR) Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Tyrosine Kinase Inhibitor (TKI) Therapy. Cancers (Basel). 2021 Mar 20; 13(6). PMID: 33804721.
      Citations:    
    16. Wakefield CJ, Hamati F, Karush JM, Arndt AT, Geissen N, Liptay MJ, Borgia JA, Basu S, Seder CW. Sarcopenia after induction therapy is associated with reduced survival in patients undergoing esophagectomy for locally-advanced esophageal cancer. J Thorac Dis. 2021 Feb; 13(2):861-869. PMID: 33717559.
      Citations:    
    17. Tarhoni I, Wakefield CJ, Kollipara R, Fidler MJ, Batus M, Bonomi P, Borgia JA. Relationship between circulating tumor-associated autoantibodies and clinical outcomes in advanced-stage NSCLC patients receiving PD-1/-L1 directed immune checkpoint inhibition. J Immunol Methods. 2021 03; 490:112956. PMID: 33434603.
      Citations:    
    18. Barengolts E, Akbar A, Layden BT, Eisenberg Y, Priyadarshini M, Borgia JA, Fhied CL, Salim M, Dugas LR. Predictors of HbA1c among Adipocytokine Biomarkers in African-American Men with Varied Glucose Tolerance. Biomedicines. 2020 Nov 20; 8(11). PMID: 33233515.
      Citations:    
    19. Pulido I, Ollosi S, Aparisi S, Becker JH, Aliena-Valero A, Benet M, Rodr?guez ML, L?pez A, Tamayo-Torres E, Chuli?-Peris L, Garc?a-Ca?averas JC, Soucheray M, Dalheim AV, Salom JB, Qiu W, Kaja S, Fern?ndez-Coronado JA, Alandes S, Alc?cer J, Al-Shahrour F, Borgia JA, Juan O, Nishimura MI, Lahoz A, Carretero J, Shimamura T. Endothelin-1-Mediated Drug Resistance in EGFR-Mutant Non-Small Cell Lung Carcinoma. Cancer Res. 2020 10 01; 80(19):4224-4232. PMID: 32747363.
      Citations:    
    20. Bonomi P, Fidler MJ, Shah P, Borgia J. Theoretical and Practical Implications of Treating Cachexia in Advanced Lung Cancer Patients. Cancers (Basel). 2019 Oct 23; 11(11). PMID: 31652685.
      Citations:    
    21. Fidler MJ, Borgia JA, Bonomi PD, Shah P. Prognostic Significance of Skeletal Muscle Loss During Early Postoperative Period in Elderly Patients with Esophageal Cancer. Ann Surg Oncol. 2019 Nov; 26(12):3807-3808. PMID: 31471841.
      Citations:    
    22. Becker JH, Gao Y, Soucheray M, Pulido I, Kikuchi E, Rodr?guez ML, Gandhi R, Lafuente-Sanchis A, Aup? M, Alc?cer Fern?ndez-Coronado J, Mart?n-Martorell P, Cremades A, Galbis-Caravajal JM, Alc?cer J, Christensen CL, Simms P, Hess A, Asahina H, Kahle MP, Al-Shahrour F, Borgia JA, Lahoz A, Insa A, Juan O, J?nne PA, Wong KK, Carretero J, Shimamura T. CXCR7 Reactivates ERK Signaling to Promote Resistance to EGFR Kinase Inhibitors in NSCLC. Cancer Res. 2019 09 01; 79(17):4439-4452. PMID: 31273063.
      Citations:    
    23. Burkart M, Schieber M, Basu S, Shah P, Venugopal P, Borgia JA, Gordon L, Karmali R. Evaluation of the impact of cachexia on clinical outcomes in aggressive lymphoma. Br J Haematol. 2019 07; 186(1):45-53. PMID: 30941741.
      Citations:    
    24. Dou Y, Zhu Y, Ai J, Chen H, Liu H, Borgia JA, Li X, Yang F, Jiang B, Wang J, Deng Y. Plasma small ncRNA pair panels as novel biomarkers for early-stage lung adenocarcinoma screening. BMC Genomics. 2018 Jul 20; 19(1):545. PMID: 30029594.
      Citations:    
    25. Musial TF, Molina-Campos E, Bean LA, Ybarra N, Borenstein R, Russo ML, Buss EW, Justus D, Neuman KM, Ayala GD, Mullen SA, Voskobiynyk Y, Tulisiak CT, Fels JA, Corbett NJ, Carballo G, Kennedy CD, Popovic J, Ramos-Franco J, Fill M, Pergande MR, Borgia JA, Corbett GT, Pahan K, Han Y, Chetkovich DM, Vassar RJ, Byrne RW, Matthew Oh M, Stoub TR, Remy S, Disterhoft JF, Nicholson DA. Store depletion-induced h-channel plasticity rescues a channelopathy linked to Alzheimer's disease. Neurobiol Learn Mem. 2018 10; 154:141-157. PMID: 29906573.
      Citations:    
    26. Yu Z, Chen H, Zhu Y, Ai J, Li Y, Gu W, Borgia JA, Zhang J, Jiang B, Chen W, Deng Y. Global lipidomics reveals two plasma lipids as novel biomarkers for the detection of squamous cell lung cancer: A pilot study. Oncol Lett. 2018 Jul; 16(1):761-768. PMID: 29963143.
      Citations:    
    27. Kanangat S, Seder CW, Pergande MR, Lobato GC, Fhied CL, Raouf MF, Liptay MJ, Borgia JA. Circulating histocompatibility antigen (HLA) gene products may help differentiate benign from malignant indeterminate pulmonary lesions. Hum Immunol. 2018 Jul; 79(7):558-563. PMID: 29656111.
      Citations:    
    28. Fidler MJ, Fhied CL, Roder J, Basu S, Sayidine S, Fughhi I, Pool M, Batus M, Bonomi P, Borgia JA. The serum-based VeriStrat? test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients. BMC Cancer. 2018 03 20; 18(1):310. PMID: 29558888.
      Citations:    
    29. Tarhoni I, Fhied CL, Pool M, Liptay MJ, Bonomi P, Seder CW, Borgia JA. Development of bead based multiplexed immunoassay for evaluation of midkine, syndecan-1, and ANGPTL4 in patient serum. J Immunoassay Immunochem. 2018; 39(1):84-98. PMID: 29309212.
      Citations:    
    30. Seder CW, Liptay MJ, Borgia JA. Reply. Ann Thorac Surg. 2018 07; 106(1):316-317. PMID: 29288018.
      Citations:    
    31. Yu Z, Chen H, Ai J, Zhu Y, Li Y, Borgia JA, Yang JS, Zhang J, Jiang B, Gu W, Deng Y. Global lipidomics identified plasma lipids as novel biomarkers for early detection of lung cancer. Oncotarget. 2017 Dec 08; 8(64):107899-107906. PMID: 29296211.
      Citations:    
    32. Karmali R, Chukkapalli V, Gordon LI, Borgia JA, Ugolkov A, Mazar AP, Giles FJ. GSK-3? inhibitor, 9-ING-41, reduces cell viability and halts proliferation of B-cell lymphoma cell lines as a single agent and in combination with novel agents. Oncotarget. 2017 Dec 29; 8(70):114924-114934. PMID: 29383130.
      Citations:    
    33. Seder CW, Arndt AT, Jordano L, Basu S, Fhied CL, Sayidine S, Chmielewski GW, Gallo K, Liptay MJ, Borgia JA. Serum Biomarkers May Prognosticate Recurrence in Node-Negative, Non-Small Cell Lung Cancers Less Than 4 Centimeters. Ann Thorac Surg. 2017 Nov; 104(5):1637-1643. PMID: 28964418.
      Citations:    
    34. Fidler MJ, Frankenberger C, Seto R, Lobato GC, Fhied CL, Sayidine S, Basu S, Pool M, Karmali R, Batus M, Lie WR, Hayes D, Mistry J, Bonomi P, Borgia JA. Differential expression of circulating biomarkers of tumor phenotype and outcomes in previously treated non-small cell lung cancer patients receiving erlotinib vs. cytotoxic chemotherapy. Oncotarget. 2017 Aug 29; 8(35):58108-58121. PMID: 28938541.
      Citations:    
    35. Karmali R, Alrifai T, Fughhi IAM, Ng R, Chukkapalli V, Shah P, Basu S, Nathan S, Szymanski-Grant K, Gordon LI, Venugopal P, Penedo FJ, Borgia JA. Impact of cachexia on outcomes in aggressive lymphomas. Ann Hematol. 2017 Jun; 96(6):951-956. PMID: 28417157.
      Citations:    
    36. Bonomi P, Batus M, Fidler MJ, Borgia JA. Practical and theoretical implications of weight gain in advanced non-small cell lung cancer patients. Ann Transl Med. 2017 Mar; 5(6):152. PMID: 28462232.
      Citations:    
    37. Derman BA, Macklis JN, Azeem MS, Sayidine S, Basu S, Batus M, Esmail F, Borgia JA, Bonomi P, Fidler MJ. Relationships between longitudinal neutrophil to lymphocyte ratios, body weight changes, and overall survival in patients with non-small cell lung cancer. BMC Cancer. 2017 02 16; 17(1):141. PMID: 28209123.
      Citations:    
    38. Jeganathan N, Predescu D, Zhang J, Sha F, Bardita C, Patel M, Wood S, Borgia JA, Balk RA, Predescu S. Rac1-mediated cytoskeleton rearrangements induced by intersectin-1s deficiency promotes lung cancer cell proliferation, migration and metastasis. Mol Cancer. 2016 09 14; 15(1):59. PMID: 27629044.
      Citations:    
    39. Lopez-Soler RI, Borgia JA, Kanangat S, Fhied CL, Conti DJ, Constantino D, Ata A, Chan R, Wang Z. Anti-vimentin Antibodies Present at the Time of Transplantation May Predict Early Development of Interstitial Fibrosis/Tubular Atrophy. Transplant Proc. 2016 Jul-Aug; 48(6):2023-33. PMID: 27569939.
      Citations:    
    40. Medairos RA, Clark J, Holoubek S, Kubasiak JC, Pithadia R, Hamid F, Chmielewski GW, Warren WH, Basu S, Borgia JA, Liptay MJ, Seder CW. Metformin exposure is associated with improved progression-free survival in diabetic patients after resection for early-stage non-small cell lung cancer. J Thorac Cardiovasc Surg. 2016 Jul; 152(1):55-61.e1. PMID: 27157918.
      Citations:    
    41. Chen H, Liu H, Zou H, Chen R, Dou Y, Sheng S, Dai S, Ai J, Melson J, Kittles RA, Pirooznia M, Liptay MJ, Borgia JA, Deng Y. Evaluation of Plasma miR-21 and miR-152 as Diagnostic Biomarkers for Common Types of Human Cancers. J Cancer. 2016; 7(5):490-9. PMID: 26958084.
      Citations:    
    42. Seder CW, Kubasiak JC, Pithadia R, Basu S, Fhied C, Tarhoni I, Davila E, Alnajjar H, Chmielewski GW, Warren WH, Liptay MJ, Borgia JA. Angiogenesis Biomarkers May Be Useful in the Management of Patients With Indeterminate Pulmonary Nodules. Ann Thorac Surg. 2015 Aug; 100(2):429-36. PMID: 26138771.
      Citations:    
    43. Karmali R, Larson ML, Shammo JM, Basu S, Christopherson K, Borgia JA, Venugopal P. Impact of insulin-like growth factor 1 and insulin-like growth factor binding proteins on outcomes in acute myeloid leukemia. Leuk Lymphoma. 2015; 56(11):3135-42. PMID: 25735964.
      Citations:    
    44. Avasarala S, Van Scoyk M, Karuppusamy Rathinam MK, Zerayesus S, Zhao X, Zhang W, Pergande MR, Borgia JA, DeGregori J, Port JD, Winn RA, Bikkavilli RK. PRMT1 Is a Novel Regulator of Epithelial-Mesenchymal-Transition in Non-small Cell Lung Cancer. J Biol Chem. 2015 May 22; 290(21):13479-89. PMID: 25847239.
      Citations:    
    45. Li Y, Rouhi O, Chen H, Ramirez R, Borgia JA, Deng Y. RNA-Seq and Network Analysis Revealed Interacting Pathways in TGF-?-Treated Lung Cancer Cell Lines. Cancer Inform. 2014; 13(Suppl 5):129-40. PMID: 25991908.
      Citations:    
    46. Gu J, Lu Y, Li F, Qiao L, Wang Q, Li N, Borgia JA, Deng Y, Lei G, Zheng Q. Identification and characterization of the novel Col10a1 regulatory mechanism during chondrocyte hypertrophic differentiation. Cell Death Dis. 2014 Oct 16; 5:e1469. PMID: 25321476.
      Citations:    
    47. Daly S, Kubasiak JC, Rinewalt D, Pithadia R, Basu S, Fhied C, Lobato GC, Seder CW, Hong E, Warren WH, Chmielewski G, Liptay MJ, Bonomi P, Borgia JA. Circulating angiogenesis biomarkers are associated with disease progression in lung adenocarcinoma. Ann Thorac Surg. 2014 Dec; 98(6):1968-75; discussion 1975. PMID: 25301368.
      Citations:    
    48. Karmali R, Dalovisio A, Borgia JA, Venugopal P, Kim BW, Grant-Szymanski K, Hari P, Lazarus H. All in the family: Clueing into the link between metabolic syndrome and hematologic malignancies. Blood Rev. 2015 Mar; 29(2):71-80. PMID: 25433571.
      Citations:    
    49. Kubasiak JC, Seder CW, Pithadia R, Basu S, Fhied C, Phillips WW, Daly S, Shersher DD, Yoder MA, Chmielewski G, Edell ES, Maldonado F, Liptay MJ, Borgia JA. Value of circulating insulin-like growth factor-associated proteins for the detection of stage I non-small cell lung cancer. J Thorac Cardiovasc Surg. 2015 Mar; 149(3):727-34.e1-3; discussion 734. PMID: 25312225.
      Citations:    
    50. Fhied C, Kanangat S, Borgia JA. Development of a bead-based immunoassay to routinely measure vimentin autoantibodies in the clinical setting. J Immunol Methods. 2014 May; 407:9-14. PMID: 24657702.
      Citations:    
    51. Gaynes JS, Micic C, Gaynes BI, Borgia JA. Quantitation of in vitro a-1 adrenergic receptor antagonist binding capacity to biologic melanin using tandem mass spectrometry. Curr Eye Res. 2013 Dec; 38(12):1214-20. PMID: 24047464.
      Citations:    
    52. Sutton P, Borgia JA, Bonomi P, Plate JM. Lyn, a Src family kinase, regulates activation of epidermal growth factor receptors in lung adenocarcinoma cells. Mol Cancer. 2013 Jul 16; 12:76. PMID: 23866081.
      Citations:    
    53. Frankenberger C, Borgia JA, Edirisinghe PD, Oegema TR. Incomplete elongation of the chondroitin sulfate linkage region on aggrecan and response to interleukin-1?. Connect Tissue Res. 2013; 54(2):123-31. PMID: 23237500.
      Citations:    
    54. Daly S, Rinewalt D, Fhied C, Basu S, Mahon B, Liptay MJ, Hong E, Chmielewski G, Yoder MA, Shah PN, Edell ES, Maldonado F, Bungum AO, Borgia JA. Development and validation of a plasma biomarker panel for discerning clinical significance of indeterminate pulmonary nodules. J Thorac Oncol. 2013 Jan; 8(1):31-6. PMID: 23201823.
      Citations:    
    55. Rinewalt D, Shersher DD, Daly S, Fhied C, Basu S, Mahon B, Hong E, Chmielewski G, Liptay MJ, Borgia JA. Development of a serum biomarker panel predicting recurrence in stage I non-small cell lung cancer patients. J Thorac Cardiovasc Surg. 2012 Dec; 144(6):1344-50; discussion 1350-1. PMID: 22982029.
      Citations:    
    56. Fidler MJ, Shersher DD, Borgia JA, Bonomi P. Targeting the insulin-like growth factor receptor pathway in lung cancer: problems and pitfalls. Ther Adv Med Oncol. 2012 Mar; 4(2):51-60. PMID: 22423264.
      Citations:    
    57. Land WH, Qiao X, Margolis DE, Ford WS, Paquette CT, Perez-Rogers JF, Borgia JA, Yang JY, Deng Y. Kernelized partial least squares for feature reduction and classification of gene microarray data. BMC Syst Biol. 2011; 5 Suppl 3:S13. PMID: 22784619.
      Citations:    
    58. Shersher DD, Vercillo MS, Fhied C, Basu S, Rouhi O, Mahon B, Coon JS, Warren WH, Faber LP, Hong E, Bonomi P, Liptay MJ, Borgia JA. Biomarkers of the insulin-like growth factor pathway predict progression and outcome in lung cancer. Ann Thorac Surg. 2011 Nov; 92(5):1805-11; discussion 1811. PMID: 21945224.
      Citations:    
    59. Chubinskaya S, Otten L, Soeder S, Borgia JA, Aigner T, Rueger DC, Loeser RF. Regulation of chondrocyte gene expression by osteogenic protein-1. Arthritis Res Ther. 2011 Mar 29; 13(2):R55. PMID: 21447156.
      Citations:    
    60. Overk CR, Borgia JA, Mufson EJ. A novel approach for long-term oral drug administration in animal research. J Neurosci Methods. 2011 Feb 15; 195(2):194-9. PMID: 21163304.
      Citations:    
    61. Kim JS, Ellman MB, An HS, van Wijnen AJ, Borgia JA, Im HJ. Insulin-like growth factor 1 synergizes with bone morphogenetic protein 7-mediated anabolism in bovine intervertebral disc cells. Arthritis Rheum. 2010 Dec; 62(12):3706-15. PMID: 20812336.
      Citations:    
    62. Patel K, Farlow EC, Kim AW, Lee BS, Basu S, Coon JS, DeCresce D, Thimothy L, Walters KA, Fhied C, Chang C, Chen SH, Faber LP, Bonomi P, Liptay MJ, Borgia JA. Enhancement of a multianalyte serum biomarker panel to identify lymph node metastases in non-small cell lung cancer with circulating autoantibody biomarkers. Int J Cancer. 2011 Jul 01; 129(1):133-42. PMID: 20824709.
      Citations:    
    63. Farlow EC, Vercillo MS, Coon JS, Basu S, Kim AW, Faber LP, Warren WH, Bonomi P, Liptay MJ, Borgia JA. A multi-analyte serum test for the detection of non-small cell lung cancer. Br J Cancer. 2010 Oct 12; 103(8):1221-8. PMID: 20859284.
      Citations:    
    64. Farlow EC, Patel K, Basu S, Lee BS, Kim AW, Coon JS, Faber LP, Bonomi P, Liptay MJ, Borgia JA. Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of non-small cell lung cancer. Clin Cancer Res. 2010 Jul 01; 16(13):3452-62. PMID: 20570928.
      Citations:    
    65. Borgia JA, Basu S, Faber LP, Kim AW, Coon JS, Kaiser-Walters KA, Fhied C, Thomas S, Rouhi O, Warren WH, Bonomi P, Liptay MJ. Establishment of a multi-analyte serum biomarker panel to identify lymph node metastases in non-small cell lung cancer. J Thorac Oncol. 2009 Mar; 4(3):338-47. PMID: 19190517.
      Citations:    
    66. Lee BS, Jayathilaka GD, Huang JS, Decresce D, Borgia JA, Zhou X, Gupta S. Modification of the immobilized metal affinity electrophoresis using sodium dodecyl sulfate polyacrylamide gel electrophoresis. Electrophoresis. 2008 Aug; 29(15):3160-3. PMID: 18633940.
      Citations:    
    67. Baronas-Lowell D, Lauer-Fields JL, Borgia JA, Sferrazza GF, Al-Ghoul M, Minond D, Fields GB. Differential modulation of human melanoma cell metalloproteinase expression by alpha2beta1 integrin and CD44 triple-helical ligands derived from type IV collagen. J Biol Chem. 2004 Oct 15; 279(42):43503-13. PMID: 15292257.
      Citations:    
    68. Malkar NB, Lauer-Fields JL, Borgia JA, Fields GB. Modulation of triple-helical stability and subsequent melanoma cellular responses by single-site substitution of fluoroproline derivatives. Biochemistry. 2002 May 14; 41(19):6054-64. PMID: 11994000.
      Citations:    
    69. Borgia JA, Malkar NB, Abbasi HU, Fields GB. Difficulties encountered during glycopeptide syntheses. J Biomol Tech. 2001 Sep; 12(3):44-68. PMID: 19499072.
      Citations:    
    70. Borgia JA, Fields GB. Chemical synthesis of proteins. Trends Biotechnol. 2000 Jun; 18(6):243-51. PMID: 10802559.
      Citations:    
    Borgia's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (315)
    Explore
    _
    Co-Authors (38)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _